Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Astrazeneca (NYSE:AZN) Rating Lowered to "Hold" at Wall Street Zen
Analysts Offer Predictions for Astrazeneca FY2026 Earnings
Sunbelt Securities Inc. Has $1.06 Million Stock Holdings in Astrazeneca Plc $AZN
Groupe la Francaise Takes Position in Astrazeneca Plc $AZN
Tempus AI Inc (TEM) (Q2 2026) Earnings Call Highlights: Revenue Surges 22% to $382. ...
Groupe la Francaise Invests $190.80 Million in Astrazeneca Plc $AZN - Stock Observer
AstraZeneca's (AZN) "Buy" Rating Reiterated at Berenberg Bank - Stock Observer
Bank of America Corp DE Has $3.76 Billion Holdings in Astrazeneca Plc $AZN
Manufacturing Stocks To Follow Now - July 27th - Daily Political
AstraZeneca reverses decision to pull lifesaving cancer and endometriosis drug Zoladex
Bank of America Corp DE Trims Stock Holdings in Astrazeneca Plc $AZN - Daily Political
Clinical toxicity of ADCs and ICI-ADC combinations: mechanisms, patterns and management
AstraZeneca (LSE:AZN) Stock In Focus After Sone Ve Win And Mixed Ultomiris Data
Astrazeneca Plc $AZN Shares Sold by Empire Financial Management Company LLC - Markets Daily
7,433 Shares in Astrazeneca Plc $AZN Acquired by Gateway Wealth Partners LLC
Astrazeneca Plc $AZN Shares Sold by Gabelli Funds LLC
Amundi Raises Stock Holdings in Astrazeneca Plc $AZN
Does AstraZeneca (LSE:AZN) Have More Value Than The Market Prices In?
Gateway Wealth Partners LLC Takes $1.47 Million Position in Astrazeneca Plc $AZN - Stock Observer
AstraZeneca CFO: AI Implementation Not Linked to Job Cuts Amid Growth, ETHRWorld
AstraZeneca Cancer Drug Targets Up to $5 Billion in Sales
Judge Dismisses AstraZeneca's Bid To Stop Maine Pharmacy Law
AstraZeneca's (AZN) Sell Rating Reiterated at Deutsche Bank Aktiengesellschaft - Markets Daily
A.P. inks pact with AstraZeneca to set up Genomic Solutions Centre in Amaravati
AstraZeneca's drug pipeine is splitting opinion among City analysts
Astrazeneca (NYSE:AZN) Posts Quarterly Earnings Results, Beats Estimates By $0.13 EPS - Markets Daily
AstraZeneca's (AZN) "Sell" Rating Reiterated at Deutsche Bank Aktiengesellschaft - Stock Observer
Astrazeneca Plc $AZN Holdings Lifted by Evelyn Partners Investment Management LLP
Astrazeneca Plc $AZN Shares Purchased by The Manufacturers Life Insurance Company
Citigroup Issues Positive Forecast for AstraZeneca (LON:AZN) Stock Price - Markets Daily
AstraZeneca reports Phase III results for Ultomiris and Sone-Ve
AstraZeneca PLC (LON:AZN) Receives £153.33 Average PT from Analysts - Markets Daily
AstraZeneca's Sone-Ve Improves Survival In Gastric Cancer Trial
How Illumina's Billion Cell Atlas Expansion Could Reshape Eli Lilly's (LLY) Drug Discovery Edge
AstraZeneca (LON:AZN) Stock Price Expected to Rise, Citigroup Analyst Says - Stock Observer
Evelyn Partners Investment Management Europe Ltd Acquires Shares of 21,991 Astrazeneca Plc $AZN - Daily Political
Astrazeneca Plc $AZN Holdings Lifted by Evelyn Partners Investment Management Services Ltd - Daily Political
GlaxoSmithKline (GSK) Receives a Hold from Deutsche Bank
Insights from integrative spatial transcriptomics in sepsis-associated acute kidney injury
D-FW Business Datebook: Tattoos, indie books and cinema earnings
AstraZeneca Earnings: As Positive News Flow Continues, More Readouts Expected In the Second Half | Morningstar
AstraZeneca PLC (AZN) Q2 2026 Earnings Call Highlights: Strong Oncology and Rare Disease Growth ...
AstraZeneca shares climb after earnings beat estimates as cancer drug portfolio drives strong growth
AstraZeneca Pressure Puts Krystal Biotech, TG Therapeutics And Gilead Stocks In Focus
Astrazeneca Q2 Earnings Call Highlights
AstraZeneca drug prices evolving in response to Trump policy, executive says
Westport Asset Management Inc. Sells 7,500 Shares of Astrazeneca Plc $AZN - Zolmax
AstraZeneca Sees 2030 Goal on Track as Cancer Drugs Drive Growth - Update | Morningstar
AstraZeneca Q2 2026 earnings beat on cancer drug sales
AstraZeneca profit rises on strong cancer drug sales
Astrazeneca (NYSE:AZN) Releases Earnings Results, Beats Estimates By $0.53 EPS
AstraZeneca quarterly net profit rises 2% on strong cancer drug sales
Sonesitatug vedotin demonstrated a statistically significant and highly clinically meaningful improvement in overall survival in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers
Market Open: Vodafone raises guidance, AstraZeneca H1 growth
AstraZeneca Q2 Pre-tax Profit Down, But EPS Rise; Backs Positive FY26 View
First Trust Advisors LP Sells 624,072 Shares of Astrazeneca Plc $AZN
AstraZeneca Posts Sales Growth on Oncology Strength | Morningstar
AstraZeneca maintains outlook as cancer, rare disease drugs drive profit beat
AstraZeneca's rare disease drug Ultomiris misses main goal in late-stage trial
AstraZeneca's rare disease drug misses main goal in late-stage trial
AstraZeneca shares climbs as full-year outlook reiterated despite recent trial failure - UPDATE
AstraZeneca earnings beat forecasts despite slight revenue miss
FTSE 100 Live: Strong start expected to busy week as AstraZeneca, Vodafone report results
AstraZeneca Stock Leads 3 Blue Chips Trading Below Fair Value
AstraZeneca quarterly net profit rises on strong cancer drug sales - Latest News
Astrazeneca (NYSE:AZN) Posts Earnings Results - Daily Political
AstraZeneca News | Markets Insider
FOMC Out Next Week with Interest Rate Decision
AstraZeneca Q2 Earnings Preview: Can Tagrisso, Imfinzi And Farxiga Sustain Momentum?
Waverly Advisors LLC Sells 118,483 Shares of Astrazeneca Plc $AZN
AstraZeneca Stock Leads 3 Cash Flow Picks Trading Below Fair Value
Ionis Pharmaceuticals (IONS) Trial Setback Sparks Scrutiny, Is The 38% Undervaluation Case Still Credible?
Wealth Alliance LLC Has $1.73 Million Stock Holdings in Astrazeneca Plc $AZN
Lido Advisors LLC Cuts Stake in Astrazeneca Plc $AZN
Compound Planning Inc. Sells 24,013 Shares of Astrazeneca Plc $AZN - Markets Daily
Astrazeneca Plc $AZN Shares Sold by Compound Planning Inc.
Lonza Group Ltd (LONN) Gets a Buy from Bernstein
PNC Financial Services Group Inc. Sells 117,223 Shares of Astrazeneca Plc $AZN - Daily Political
Business Weekly Awards 2026: 44 shortlisted companies revealed for Cambridge Tech and Life Sciences showcase
Weekly Buzz: AZN, GSK JNJ Approvals; CUV Layoff, REGN, HALO, Samsun Deals, LLY, CLDX Data
Public Employees Retirement System of Ohio Buys 677,700 Shares of Astrazeneca Plc $AZN
Analysis-AstraZeneca 'magic' faces rare test after trial failure, share slide - AOL
UK Stocks That May Be Trading Below Their Estimated Value
How Eplontersen's Phase 3 Setback And Scrutiny At Ionis Pharmaceuticals (IONS) Has Changed Its Investment Story
Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study
AstraZeneca Stock Looks Undervalued on Cash Flow Alongside Two UK Shares
AstraZeneca immune from Covid-19 vaccine injury lawsuit | Courthouse News Service
Astrazeneca Plc $AZN Shares Sold by Glenview Trust Co - Markets Daily
AstraZeneca Wins EU Approval for Breast-Cancer Drug as U.S. Review Continues | Morningstar
Glenview Trust Co Trims Position in Astrazeneca Plc $AZN - Stock Observer
AZN Investors Have Opportunity to Join AstraZeneca PLC Fraud Investigation with the Schall Law Firm | Morningstar
Disease modification in lupus nephritis: towards a pathophysiology-based treatment paradigm
Latest news
Show more
Gold Price Today, July 31: Gold Holds Near $4,100 After Softer US Inflation
Oil Prices Fall as Hormuz Traffic Improves, but Supply Risks Remain
Sandisk Shares Surge 26% as Microsoft Earnings Revive AI Memory Trade
Bitcoin Price Analysis Today: BTC Slides Toward $63,600 After Rejection at $65,800
NIO Stock News Today July 31: Shares Extend Rally as Deliveries and Profitability Outlook Improve
